InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: Rentier post# 12031

Monday, 07/03/2017 12:48:20 AM

Monday, July 03, 2017 12:48:20 AM

Post# of 16911
yes an injectable will not be comparable in price to a generic pill, but it should be priced competitively in order to spur adoption of the technology that is more effective and thus will ultimately cost insurance companies less than the current ineffective sublingual or generic pill treatment they pay for.. to whit: 1 ER visit for emergency resuscitation will cost insurance about $30000.. all the medical sequalae that revolve around untreated opioid substance abuse is darn expensive for an insurance company vs the cost of the implant ... is anyone presenting data on this?... still if the price initially is significantly higher than the generic sublingual pill then that is a barrier to quick adoption of the procedure and should be adjusted accordingly
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News